Across TCGA patient cohorts, ZBED6CL mutation is significantly associated with the RNA expression of many other genes, with 1,608 significant associations in total. UCEC shows the largest number of these associations.

The most reproducible ZBED6CL-associated genes across cancer lineages are PRADC1P1, RN7SL248P, and CDK2. Each is linked with ZBED6CL in more than 1 cancer types. Because this analysis shows association rather than direction, both ZBED6CL-to-partner and partner-to-ZBED6CL results are reported.

Each partner links to its own Q-omics profile.

mutation associated genes by consensus

Ranked by combined sampling and lineage consensus. X-score (ZBED6CL→partner) and Y-score (partner→ZBED6CL) are standardized regression coefficients; both directions are reported because the association is undirected. p-values are from the association test.

Lineage	Partner gene	X-score	Y-score	p(X)	p(Y)	Sampling consensus	Lineage consensus
SKCM	PRADC1P1 →	+0.534	+3.360	.003	.005	3	2
UCEC	RN7SL248P →	+0.098	+4.022	<.001	<.001	3	2
UCEC	CDK2 →	+0.687	+3.378	.001	.004	3	2
UCEC	BAHD1 →	+0.547	+2.906	.002	.002	3	2
SKCM	SH2D5 →	+0.726	+3.591	.001	.001	3	2
SKCM	MED28P1 →	+0.142	+2.841	.003	.003	3	2

Each partner links to its Q-omics profile. Showing the 6 strongest of 1,608 associations by consensus.

Exploration

ZBED6CL survival (RNA) · tumor vs normal (RNA) · all ZBED6CL data types